Research Study

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Principal Investigator 
Jacqueline Saw

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT02928497
Status 
Recruiting
Study Start/End 
Sep 5, 2018 to Dec 31, 2023
Locations 
Vancouver General Hospital
Name/Title 
Naomi Uchida, Clinical Research Coordinator
Phone 
604-875-4521
Email Address 
naomi.uchida@ubc.ca
Purpose of Study 

The purpose of this study is to establish the safety and effectiveness of the WATCHMAN Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the risk of stroke.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.